GCG and metabolic dysfunction-associated steatotic liver disease: Yang et al. (25) demonstrated that Ex-4 can reduce lipid accumulation in high glucose and free fatty acid co-cultured HepG2 cells, indicating the effectiveness of the GLP-1 analogue in managing NAFLD by regulating lipid metabolism in hepatocytes.